The Latest Cardiac and Vascular News
Proven Leader Will Take Revolutionary Heart Failure Therapy Company to Next Level SAN RAMON, Calif.–(BUSINESS WIRE)–BioVentrix, Inc., a privately held medical device company focused on treating congestive heart failure (CHF) via Transcatheter-based Ventricular Restoration (TCVR), today announced that Jim Dillon has been named President and CEO. In his role, Mr. […]
MORRISVILLE, N.C., April 28, 2021 /PRNewswire/ — A new peer-reviewed study accepted in the Journal of the American College of Cardiology: Cardiovascular Imaging validated Myocardial Solutions (“MSI”) technologies MyoStrain and MyoStress in a new stress testing protocol utilizing a hyperventilation breath-hold (HVBH) maneuver to accurately detect myocardial ischemia. The article demonstrated MyoStrain’s speed and sensitivity […]
Published Study Shows Combined Decrease in Heart Attacks and Strokes Among MDVIP Patients Relative to the General Population BOCA RATON, Fla., April 29, 2021 /PRNewswire/ — New research from MDVIP shows that its personalized and preventive approach to primary care helps reduce the incidence of cardiovascular events in at-risk patients. The study, […]
Cardiologists at Henry Ford Hospital Led the Development of Shock Treatment Protocol DETROIT, April 28, 2021 /PRNewswire/ — The results of a large, national heart attack study show that patients with a deadly complication known as cardiogenic shock survived at a significantly higher rate when treated with a protocol developed by cardiologists at […]
LJUBLJANA, Slovenia, April 29, 2021 /PRNewswire/ — MESI mTABLET ABI, device used for early detection of Peripheral Arterial Disease (PAD) by measuring Ankle-Brachial Index (ABI), has been announced as a finalist in the Cardiovascular Device category in the 2021 Medical Design Awards (MDEA) competition. MDEA is the premier awards program for the MedTech […]
FRANKLIN LAKES, N.J., April 29, 2021 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that enrollment has begun and the first patients have been treated in the post-market surveillance study, CONNECT-AV. CONNECT-AV is a prospective, single-arm, open-label study that will follow patients treated with […]
Device further expands the range of blood vessels that can now be treated for ischemic stroke. NETANYA, Israel, April 29, 2021 /PRNewswire/ — Perflow Medical, a private, Israeli-based innovator for neurovascular treatments, today announced the first successful clinical use of the Stream™17 Dynamic Neuro-Thrombectomy Net, a lower profile device designed for more tortuous anatomy, […]
Commercial Launch of VAZKEPA in Europe on Track to Commence in Q3 2021 Following Recent Market Authorization with VASCEPA® Growth in the United States Positioned to Increase as the Impact of COVID-19 Recedes Expenses Managed in Q1 2021 to Minimize Operating Loss Despite Revenue Impact of COVID-19 and Other Factors […]
TEL AVIV, Israel, April 29, 2021 (GLOBE NEWSWIRE) — InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of the stroke caused by carotid artery disease, today announces the formation of its Scientific Advisory Board with its newly appointed chair, acclaimed interventional cardiologist, […]
SILVER SPRING, Md., April 28, 2021 (GLOBE NEWSWIRE) — Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, announced today the initiation of a multi-center observational study to provide insight into the clinical […]
